Literature DB >> 2307451

Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease.

M Terai1, Y Kohno, M Namba, T Umemiya, K Niwa, H Nakajima, A Mikata.   

Abstract

To investigate the class II major histocompatibility antigen expression on coronary arterial endothelium of Kawasaki disease and immunophenotypes of the infiltrating cells in the coronary vascular lesions, myocardial sections from a patient who died during the acute stage of Kawasaki disease were studied using an immunoperoxidase technique. The mononuclear cells in the lesions mainly consisted of macrophages and T cells, whereas B cells and NK/K cells were not seen. The majority of T cells reacted with Leu-3a antibodies, and only a few reacted with Leu-2a antibodies. Cells bearing the interleukin-2 receptor, indicative of activated T cells, were also found in the lesions. To determine the distribution of class II antigen, we used anti-HLA-DR antibodies. The massive expression of HLA-DR antigen on mononuclear cells was found in the lesions. In addition, the HLA-DR activation antigen was expressed on the coronary arterial endothelium at the infiltrates in which macrophages and T cells coexisted. In contrast, coronary arterial endothelium did not express HLA-DR antigens in the myocardial tissues of controls (n = 4). HLA-DR+ endothelial cells may play an important role in the development of Kawasaki vasculitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307451     DOI: 10.1016/0046-8177(90)90135-r

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  24 in total

1.  CD14+CD16+ monocyte subpopulation in Kawasaki disease.

Authors:  K Katayama; T Matsubara; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 2.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 3.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 4.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

5.  Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.

Authors:  S A Cameron; S M White; D Arrollo; S T Shulman; A H Rowley
Journal:  Clin Exp Immunol       Date:  2017-08-07       Impact factor: 4.330

6.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

7.  Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways.

Authors:  Nana Nie; Cui Bai; Shanai Song; Yanyan Zhang; Benzhen Wang; Zipu Li
Journal:  Mol Cell Biochem       Date:  2019-11-18       Impact factor: 3.396

8.  Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children.

Authors:  Fu-Yuan Huang; Tzu-Yang Chang; Ming-Ren Chen; Hung-Chang Lee; Hsin Chi; Nan-Chang Chiu; Chyong-Hsin Hsu; Shuan-Pei Lin; Hsin-An Kao; Wei-Fang Chen; Hui-Wen Chan; Hsin-Fu Liu; Chen-Chung Chu; Marie Lin; Yann-Jinn Lee
Journal:  J Clin Immunol       Date:  2008-02-23       Impact factor: 8.317

9.  Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease.

Authors:  Danica J Schulte; Atilla Yilmaz; Kenichi Shimada; Michael C Fishbein; Emily L Lowe; Shuang Chen; Michelle Wong; Terence M Doherty; Thomas Lehman; Timothy R Crother; Rosalinda Sorrentino; Moshe Arditi
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

10.  T cell activation profiles in Kawasaki syndrome.

Authors:  P A Brogan; V Shah; L A Clarke; M J Dillon; N Klein
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.